| Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms JH Harger, SP Adler, WC Koch, GF Harger Obstetrics & Gynecology 91 (3), 413-420, 1998 | 202 | 1998 |
| Human parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients J Jordan, B Tiangco, J Kiss, W Koch Vox sanguinis 75 (2), 97-102, 1998 | 172 | 1998 |
| Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients WC Koch, G Massey, CE Russell, SP Adler The Journal of pediatrics 116 (3), 355-359, 1990 | 160 | 1990 |
| Detection of human parvovirus B19 DNA by using the polymerase chain reaction WC Koch, SP Adler Journal of Clinical Microbiology 28 (1), 65-69, 1990 | 154 | 1990 |
| Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review G Nigro, V Bastianon, V Colloridi, F Ventriglia, P Gallo, G D'Amati, ... Clinical infectious diseases 31 (1), 65-69, 2000 | 141 | 2000 |
| Human parvovirus B19 infections in women of childbearing age and within families. WC Koch, SP Adler The Pediatric infectious disease journal 8 (2), 83-87, 1989 | 134 | 1989 |
| Failure to thrive due to obstructive sleep apnea AD Everett, WC Koch, FT Saulsbury Clinical pediatrics 26 (2), 90-92, 1987 | 130 | 1987 |
| Serologic and virologic evidence for frequent intrauterine transmission of human parvovirus B19 with a primary maternal infection during pregnancy WC Koch, JH Harger, B Barnstein, SP Adler The Pediatric infectious disease journal 17 (6), 489-494, 1998 | 118 | 1998 |
| Risk of human parvovirus B19 infections among school and hospital employees during endemic periods SP Adler, AMA Manganello, WC Koch, SH Hempfling, AM Best Journal of Infectious Diseases 168 (2), 361-368, 1993 | 91 | 1993 |
| Fifth (human parvovirus) and sixth (herpesvirus 6) diseases WC Koch Current Opinion in Infectious Diseases 14 (3), 343-356, 2001 | 83 | 2001 |
| Antivirals for cytomegalovirus infection in neonates and infants: focus on pharmacokinetics, formulations, dosing, and adverse events BC Marshall, WC Koch Pediatric Drugs 11, 309-321, 2009 | 80 | 2009 |
| Parvovirus B19 in anemic liver transplant recipients OK Ndimbie, E Frezza, JA Jordan, W Koch, DH Van Thiel Clinical Diagnostic Laboratory Immunology 3 (6), 756-760, 1996 | 40 | 1996 |
| Intrauterine parvovirus B19 infection may cause an asymptomatic or recurrent postnatal infection WC KOCH, SP ADLER, J HARGER The Pediatric infectious disease journal 12 (9), 747-750, 1993 | 39 | 1993 |
| Parvovirus B19 infection in patients with hemophilia MV Ragni, WC Koch, JA Jordan Transfusion 36 (3), 238-241, 1996 | 36 | 1996 |
| A synthetic parvovirus B19 capsid protein can replace viral antigen in antibody-capture enzyme immunoassays WC Koch Journal of virological methods 55 (1), 67-82, 1995 | 35 | 1995 |
| Parvovirus B19 WC Koch Nelson Textbook of Pediatrics, 1094-1097. e1, 2011 | 22 | 2011 |
| Human parvovirus infections SP Adler, WC Koch Infectious diseases of the fetus and newborn infant, 867-892, 2006 | 14 | 2006 |
| Human parvovirus SP Adler, WC Koch Infectious diseases of the fetus and newborn, 834-860, 2011 | 12 | 2011 |
| A cluster of transfusion-associated babesiosis in extremely low birthweight premature infants P Kumar, BC Marshall, G Deblois, WC Koch Journal of Perinatology 32 (9), 731-733, 2012 | 10 | 2012 |
| Aplastic crisis WC Koch, GV Massey Pediatrics in Review 12 (5), 142-148, 1990 | 6 | 1990 |
